European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines
Por:
Karagiannis, T, Advani, A, Davies, MJ, Del Prato, S, Dinneen, SF, Kuss, O, Lorenzoni, V, Mathieu, C, Mauricio, D, Tankova, T, Zaccardi, F, Holt, RIG, Tsapas, A, EASD Guidelines Oversight Comm
Publicada:
1 ago 2025
Ahead of Print:
1 may 2025
Resumen:
The European Association for the Study of Diabetes (EASD) has developed a Standard Operating Procedure (SOP) for the development of clinical practice guidelines, ensuring adherence to rigorous methodological standards based on the principles of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. Key components include a transparent process for managing conflicts of interest, the incorporation of multidisciplinary panels including individuals with lived experience of diabetes, an evidence synthesis based on comprehensive systematic reviews, and an explicit peer review process. This SOP delineates the roles and responsibilities of the main structures involved, including the Guidelines Oversight Committee, Guideline Development Panels, and Evidence Synthesis Teams. Additionally, the SOP describes the main stages in guideline development, namely scoping of the guideline topic, evidence synthesis, development of Evidence-to-Decision frameworks for the formulation of clear, patient-centred recommendations, writing of the guideline document and the review process.
Filiaciones:
Karagiannis, T:
Aristotle Univ Thessaloniki, Med Dept 2, Clin Res & Evidence Based Med Unit, Thessaloniki, Greece
Advani, A:
St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada
Davies, MJ:
Univ Leicester, Diabet Res Ctr, Leicester, England
NIHR Leicester Biomed Res Ctr, Leicester, England
Del Prato, S:
Interdisciplinary Res Ctr Hlth Sci, Sch Adv Studies, Pisa, Italy
Dinneen, SF:
Galway Univ Hosp, Ctr Diabet Endocrinol & Metab, Galway, Ireland
Univ Galway, Discipline Med, Galway, Ireland
Kuss, O:
Heinrich Heine Univ Dusseldorf, Inst Biometr & Epidemiol, Leibniz Inst Diabet Res, German Diabet Ctr, Dusseldorf, Germany
Lorenzoni, V:
Scuola Super Sant Anna, Inst Management, Pisa, Italy
Mathieu, C:
Katholieke Univ Leuven, Dept Endocrinol, UZ Gasthuisberg, Leuven, Belgium
Mauricio, D:
Hosp Santa Creu i Sant Pau, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Dept Endocrinol & Nutr, IR Sant Pau, Barcelona, Spain
Tankova, T:
Med Univ Sofia, Dept Endocrinol, Sofia, Bulgaria
Zaccardi, F:
Univ Leicester, Diabet Res Ctr, Leicester, England
Univ Leicester, Leicester Real World Evidence Unit, Leicester, England
Holt, RIG:
Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, England
Univ Hosp Southampton NHS Fdn Trust, Natl Inst Hlth, Care Res Southampton Biomed Res Ctr, Southampton, England
Tsapas, A:
Aristotle Univ Thessaloniki, Med Dept 2, Clin Res & Evidence Based Med Unit, Thessaloniki, Greece
Aristotle Univ Thessaloniki, Diabet Ctr, Med Dept 2, Thessaloniki, Greece
Green Submitted, hybrid
|